Lifestyle Interventions to Prevent Diabetes in U.S. Home Visiting Programs

NCT06988306 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 978

Last updated 2026-03-05

No results posted yet for this study

Summary

The study is examining the health effects of gestational diabetes mellitus (GDM) intervention and medically tailored meals within home visiting. A large study is proposed that will include nearly a thousand pregnant or recently pregnant adults with recent GDM and who are from different regions and backgrounds. Two treatment approaches are compared, and both are in home visiting. One treatment group is receiving enhanced lifestyle support for GDM along with meals, and the other is receiving just the enhanced lifestyle support. The study will examine whether these interventions help reduce diabetes and pre-diabetes through 12 months postpartum, as well as other health factors like weight and blood pressure.

Conditions

Interventions

BEHAVIORAL

GDM Enhanced

The GDM Enhanced intervention is comprised of HV-delivered, evidence-based modules (10-20 minutes) with facilitator guides. The content prioritizes management and prevention of diabetes through healthy eating, physical activity, and stigma-informed weight management strategies.

BEHAVIORAL

Meals

The Meal intervention includes medically tailored meals being provided to participants starting after randomization and tailored to their individual dietary preferences and cultural considerations.

Sponsors & Collaborators

  • Lifespan/ The Miriam Hospital

    collaborator UNKNOWN
  • Northwestern University

    collaborator OTHER
  • Bradley Hospital

    collaborator OTHER
  • Patient-Centered Outcomes Research Institute

    collaborator OTHER
  • California Polytechnic State University-San Luis Obispo

    lead OTHER

Principal Investigators

  • Suzanne Phelan, PhD · California Polytechnic State University-San Luis Obispo

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-15
Primary Completion
2030-04-30
Completion
2030-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06988306 on ClinicalTrials.gov